I think that part of the issue is that THC containing products tend to have much worse side-effects so are less likely to be licensed by companies
Pretty much. Firm conclusions about benefit are misleading, but harms have been quite robustly demonstrated. Hence my caution
-
-
No causal link demonstrated for psychosis. Cochrane review ignores Israeli research.
-
There is a strong and consistent association between psychosis and cannabis use. It ~may~ still turn out to be coincidence, but it is extremely unlikely. And unless you have a specific criticism of the Cochrane methodology, by design they did not ignore any research
- Show replies
New conversation -
-
-
I think the epilepsy part of your article is misleading, costs/side effects of other medications are significant. On PBS you get given cheapest Benz variant.
-
Maybe this is more a criticism of cost efficiency in the PBS, but the reality is that patients have to deal with these things outside of a simulation.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.